1-Dec-2008
Subscription Info
|
Institutional Access
|
Browse the Faculties
|
Free Trial
|
Take a Tour
|
Top 10s
|
Advanced Search
|
Faculty Member List
|
About
Search
All F1000 Medicine
Diabetes & Endoc...
Top 10s
Diabetes & Endocrinology
Current Top 10 by F1000 Factor
All Time Top 10 by F1000 Factor
Most viewed Top 10
(from all journals)
Most viewed Top 10
(from specialty journals)
Hidden Jewels
Sections Covered
Adrenal Cortex
Bone & Mineral Metabolism
Diabetes & Obesity
Multiple Endocrine Disorders & Neoplasias
Neuro-Endocrinology & Pituitary
Reproductive Endocrinology
Thyroid
Related Sections
Female Subfertility & Gynecological Endocrinology
ALL TIME TOP 10 BY F1000 FACTOR | Diabetes & Endocrinology | calculated on 1 December 2008
All Time Top 10 By F1000 Factors are generated every day using papers added to F1000 Medicine since the project started (Top 10s consider papers evaluated in the preceding month). Papers are ranked according to their
F1000 Factor
which incorporates both the number of times a paper has been evaluated, and the ratings it received. If any papers have an equal F1000 Factor then the most recently added paper is listed first.
browse faculty
| show All Time Top 10 in
ALL OF MEDICINE
Anesthesiology & Pain Management
Cardiovascular Disorders
Critical Care & Emergency Medicine
Dermatology
Diabetes & Endocrinology
Gastroenterology & Hepatology
Hematology
Infectious Diseases
Nephrology
Neurological Disorders
Oncology
Psychiatry
Public Health & Epidemiology
Research Methodology
Respiratory Disorders
Rheumatology & Clinical Immunology
Urology
Women's Health
selected articles
all 10 items
to
EndNote
Ref. Manager
RefWorks
Bibtex
ProCite
email [
Help
]
1
Exceptional
F1000 Factor
9.7
Hypothesis
New Finding
Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7.
Wajapeyee N, Serra RW, …, Mahalingam M, Green MR
Cell
2008 Feb 8
132
(3):363-74 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Barry Nelkin / Boris Bastian / Mina Yaar
First evaluation 4 Mar 2008 | Latest evaluation 11 Mar 2008
2
Exceptional
F1000 Factor
9.6
Hypothesis
New Finding
Controversial
Targeted ablation of osteocytes induces osteoporosis with defective mechanotransduction.
Tatsumi S, Ishii K, …, Takeshita S, Ikeda K
Cell Metab
2007 Jun
5
(6):464-75 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Larry Suva / Daniel Bikle
First evaluation 25 Jun 2007 | Latest evaluation 29 Oct 2007
3
Exceptional
F1000 Factor
9.0
New Finding
AMPK and PPARdelta agonists are exercise mimetics.
Narkar VA, Downes M, …, Shaw RJ, Evans RM
Cell
2008 Aug 8
134
(3):405-15 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Daniel Carson
Evaluated 17 Oct 2008
4
Exceptional
F1000 Factor
9.0
New Finding
The extracellular calcium-sensing receptor (CaSR) is a critical modulator of skeletal development.
Chang W, Tu C, …, Bikle D, Shoback D
Sci Signal
2008
1
(35):ra1 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Peter Fuller
Evaluated 9 Oct 2008
5
Exceptional
F1000 Factor
9.0
Hypothesis
New Finding
Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study.
Richards JB, Rivadeneira F, …, Uitterlinden AG, Spector TD
Lancet
2008 May 3
371
(9623):1505-12 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Jon Tobias with Emma Clark
Evaluated 14 Jul 2008
6
Exceptional
F1000 Factor
9.0
New Finding
SUMOylation of Krüppel-like transcription factor 5 acts as a molecular switch in transcriptional programs of lipid metabolism involving PPAR-delta.
Oishi Y, Manabe I, …, Kadowaki T, Nagai R
Nat Med
2008 Jun
14
(6):656-66 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Zecharia Madar
Evaluated 11 Jun 2008
7
Exceptional
F1000 Factor
9.0
Confirmation
Desmoplasia in medullary thyroid carcinoma: a reliable indicator of metastatic potential.
Koperek O, Scheuba C, …, Niederle B, Kaserer K
Histopathology
2008 Apr
52
(5):623-30 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| JWM Hoeppener
Evaluated 6 Jun 2008
8
Exceptional
F1000 Factor
9.0
New Finding
Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma.
Jazdzewski K, Murray EL, …, Schoenberg DR, de la Chapelle A
Proc Natl Acad Sci U S A
2008 May 20
105
(20):7269-74 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Gilbert Cote
Evaluated 5 Jun 2008
9
Exceptional
F1000 Factor
9.0
New Finding
Endocrine disruptors and the thyroid gland--a combined in vitro and in vivo analysis of potential new biomarkers.
Schmutzler C, Gotthardt I, …, Wuttke W, Köhrle J
Environ Health Perspect
2007 Dec
115 Suppl 1
:77-83 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Ulla Feldt-Rasmussen
Evaluated 25 Apr 2008
10
Exceptional
F1000 Factor
9.0
New Finding
Motif module map reveals enforcement of aging by continual NF-kappaB activity.
Adler AS, Sinha S, …, Segal E, Chang HY
Genes Dev
2007 Dec 15
21
(24):3244-57 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Daniel Carson
Evaluated 12 Mar 2008
© 2008 Medicine Reports Ltd unless otherwise stated.
< info@f1000.com >
Terms and conditions
Legal info